Daniel Leblanc

Daniel Leblanc is Chief Manufacturing and Supply Officer at eGenesis and brings more than 25 years of global biopharmaceutical industry experience spanning manufacturing, technical operations, quality, supply chain, and commercialization. He has extensive expertise in advancing complex therapeutic technologies from early development through regulatory approval and commercial manufacturing.

Before joining eGenesis, Mr. Leblanc served as Chief Technology Officer at Ensoma, where he played a key role in establishing the company’s technical operations, quality, and supply chain functions, as well as its external manufacturing network to support clinical development of its in vivo gene therapy platform. Previously, he held senior leadership positions at Flexion Therapeutics, most recently as Senior Vice President of Chemistry, Manufacturing and Controls (CMC) Operations, where he played a central role in the development, scale-up, and commercialization of Zilretta, an extended-release microsphere therapy. Earlier in his career, Mr. Leblanc held CMC and manufacturing leadership positions at Merck Serono and Alkermes.

Throughout his career, Mr. Leblanc has led manufacturing strategy, process development, quality systems, and global supply operations to support the clinical advancement and commercialization of innovative therapies.

Mr. Leblanc holds an Executive Master’s in Technology Management from the University of Pennsylvania’s Wharton School and School of Engineering and Applied Science, and a B.S. in Chemical Engineering from Syracuse University.